Concepts (231)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hepatorenal Syndrome | 1 | 2018 | 61 | 0.600 |
Why?
|
| Mastocytosis, Systemic | 1 | 2018 | 100 | 0.560 |
Why?
|
| Liver Transplantation | 7 | 2023 | 2119 | 0.550 |
Why?
|
| Liver Failure | 1 | 2018 | 241 | 0.530 |
Why?
|
| Calpain | 4 | 2006 | 150 | 0.410 |
Why?
|
| Kidney Transplantation | 7 | 2018 | 4251 | 0.400 |
Why?
|
| Ascites | 1 | 2013 | 344 | 0.400 |
Why?
|
| SKP Cullin F-Box Protein Ligases | 3 | 2006 | 177 | 0.390 |
Why?
|
| Hernia, Ventral | 1 | 2013 | 176 | 0.380 |
Why?
|
| Death | 2 | 2011 | 678 | 0.350 |
Why?
|
| Muscle Proteins | 5 | 2006 | 1159 | 0.340 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2011 | 369 | 0.320 |
Why?
|
| Glycogen Synthase Kinase 3 | 2 | 2005 | 430 | 0.280 |
Why?
|
| Muscle Fibers, Skeletal | 3 | 2005 | 555 | 0.270 |
Why?
|
| Cutaneous Fistula | 1 | 2006 | 78 | 0.270 |
Why?
|
| Clinical Clerkship | 2 | 2022 | 532 | 0.260 |
Why?
|
| Intestinal Fistula | 1 | 2006 | 140 | 0.260 |
Why?
|
| Muscular Atrophy | 2 | 2006 | 349 | 0.260 |
Why?
|
| Kidney Failure, Chronic | 1 | 2018 | 2538 | 0.260 |
Why?
|
| Tissue Donors | 2 | 2011 | 2240 | 0.250 |
Why?
|
| Liver Cirrhosis | 3 | 2021 | 1863 | 0.240 |
Why?
|
| Students, Medical | 3 | 2022 | 1862 | 0.240 |
Why?
|
| Hyperparathyroidism, Primary | 1 | 2006 | 160 | 0.240 |
Why?
|
| Living Donors | 3 | 2023 | 620 | 0.230 |
Why?
|
| Tissue and Organ Procurement | 1 | 2011 | 896 | 0.220 |
Why?
|
| Sepsis | 3 | 2006 | 2593 | 0.220 |
Why?
|
| Ubiquitin-Protein Ligases | 3 | 2006 | 1861 | 0.210 |
Why?
|
| Dexamethasone | 3 | 2006 | 1951 | 0.210 |
Why?
|
| Graft Survival | 4 | 2018 | 3737 | 0.200 |
Why?
|
| Muscles | 1 | 2006 | 1614 | 0.200 |
Why?
|
| Endovascular Procedures | 3 | 2021 | 1979 | 0.190 |
Why?
|
| Drug Costs | 1 | 2018 | 1105 | 0.190 |
Why?
|
| Clinical Enzyme Tests | 1 | 2020 | 115 | 0.180 |
Why?
|
| Diagnostic Errors | 1 | 2007 | 1257 | 0.180 |
Why?
|
| Aspartate Aminotransferases | 1 | 2020 | 418 | 0.160 |
Why?
|
| General Surgery | 2 | 2020 | 1636 | 0.160 |
Why?
|
| Hepatic Artery | 1 | 2018 | 245 | 0.150 |
Why?
|
| Platelet Count | 1 | 2020 | 781 | 0.150 |
Why?
|
| Gynecology | 1 | 2022 | 513 | 0.140 |
Why?
|
| Immunosuppressive Agents | 2 | 2018 | 4149 | 0.140 |
Why?
|
| Graft Rejection | 2 | 2018 | 4397 | 0.140 |
Why?
|
| Adenoma | 1 | 2007 | 2174 | 0.140 |
Why?
|
| Bullying | 1 | 2018 | 210 | 0.130 |
Why?
|
| Obstetrics | 1 | 2022 | 658 | 0.130 |
Why?
|
| Calcium | 2 | 2006 | 5756 | 0.130 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2018 | 549 | 0.130 |
Why?
|
| Aortic Aneurysm | 1 | 2020 | 643 | 0.130 |
Why?
|
| Specialties, Surgical | 1 | 2019 | 391 | 0.120 |
Why?
|
| End Stage Liver Disease | 1 | 2018 | 314 | 0.120 |
Why?
|
| Angioplasty, Balloon | 1 | 2018 | 653 | 0.120 |
Why?
|
| Blood Group Incompatibility | 1 | 2015 | 146 | 0.120 |
Why?
|
| Postoperative Complications | 4 | 2021 | 15295 | 0.120 |
Why?
|
| Thyroid Neoplasms | 1 | 2007 | 2282 | 0.120 |
Why?
|
| Blood Vessel Prosthesis Implantation | 2 | 2021 | 1390 | 0.110 |
Why?
|
| Donor Selection | 1 | 2015 | 201 | 0.110 |
Why?
|
| ABO Blood-Group System | 1 | 2015 | 367 | 0.110 |
Why?
|
| Learning | 2 | 2020 | 1713 | 0.110 |
Why?
|
| Laparotomy | 1 | 2014 | 473 | 0.100 |
Why?
|
| Antilymphocyte Serum | 1 | 2013 | 492 | 0.100 |
Why?
|
| Delayed Graft Function | 1 | 2011 | 48 | 0.100 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2021 | 1186 | 0.100 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2020 | 1008 | 0.100 |
Why?
|
| Cold Ischemia | 1 | 2011 | 65 | 0.100 |
Why?
|
| Muscle, Skeletal | 5 | 2006 | 4931 | 0.100 |
Why?
|
| Emergencies | 2 | 2014 | 1170 | 0.090 |
Why?
|
| Curriculum | 2 | 2022 | 3605 | 0.090 |
Why?
|
| Organ Transplantation | 1 | 2019 | 1139 | 0.080 |
Why?
|
| Blood Platelets | 1 | 2020 | 2508 | 0.080 |
Why?
|
| Thiadiazoles | 2 | 2005 | 55 | 0.080 |
Why?
|
| Lithium Chloride | 2 | 2005 | 87 | 0.080 |
Why?
|
| Male | 25 | 2021 | 350118 | 0.080 |
Why?
|
| Treatment Outcome | 10 | 2020 | 63114 | 0.080 |
Why?
|
| Steroids | 1 | 2013 | 930 | 0.080 |
Why?
|
| Fluorodeoxyglucose F18 | 2 | 2015 | 2016 | 0.080 |
Why?
|
| Retrospective Studies | 12 | 2021 | 77449 | 0.080 |
Why?
|
| Middle Aged | 15 | 2019 | 213383 | 0.070 |
Why?
|
| Intraoperative Complications | 1 | 2014 | 1198 | 0.070 |
Why?
|
| Waiting Lists | 1 | 2011 | 692 | 0.070 |
Why?
|
| Perfusion | 1 | 2011 | 1360 | 0.070 |
Why?
|
| Carcinoma, Medullary | 1 | 2007 | 123 | 0.070 |
Why?
|
| Italy | 1 | 2018 | 832 | 0.070 |
Why?
|
| Glucocorticoids | 2 | 2005 | 2107 | 0.070 |
Why?
|
| Lower Extremity | 1 | 2013 | 1158 | 0.070 |
Why?
|
| Humans | 27 | 2023 | 744343 | 0.060 |
Why?
|
| Risk Assessment | 4 | 2021 | 23338 | 0.060 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2005 | 103 | 0.060 |
Why?
|
| Water-Electrolyte Balance | 1 | 2006 | 346 | 0.060 |
Why?
|
| Drug Administration Schedule | 2 | 2018 | 4933 | 0.060 |
Why?
|
| Thyroidectomy | 2 | 2007 | 879 | 0.060 |
Why?
|
| Ischemia | 1 | 2013 | 1907 | 0.060 |
Why?
|
| Nutritional Support | 1 | 2006 | 168 | 0.060 |
Why?
|
| Enzyme Inhibitors | 2 | 2005 | 3798 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2006 | 8301 | 0.060 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2018 | 3923 | 0.060 |
Why?
|
| Aged | 12 | 2020 | 163280 | 0.060 |
Why?
|
| Female | 19 | 2021 | 380194 | 0.060 |
Why?
|
| Length of Stay | 2 | 2014 | 6309 | 0.060 |
Why?
|
| Transplantation Tolerance | 1 | 2018 | 617 | 0.060 |
Why?
|
| Calcium-Binding Proteins | 2 | 2006 | 1081 | 0.060 |
Why?
|
| Positron-Emission Tomography | 3 | 2015 | 6234 | 0.060 |
Why?
|
| Cost Savings | 1 | 2018 | 926 | 0.060 |
Why?
|
| Phosphates | 1 | 2006 | 786 | 0.050 |
Why?
|
| Fetal Diseases | 1 | 2008 | 903 | 0.050 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2015 | 2214 | 0.050 |
Why?
|
| RNA, Messenger | 3 | 2006 | 13033 | 0.050 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2007 | 1094 | 0.050 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2006 | 1338 | 0.050 |
Why?
|
| Peptide Hydrolases | 1 | 2005 | 634 | 0.050 |
Why?
|
| Time Factors | 6 | 2020 | 40075 | 0.050 |
Why?
|
| Carcinoma, Papillary | 1 | 2007 | 783 | 0.050 |
Why?
|
| Caspases | 1 | 2004 | 928 | 0.050 |
Why?
|
| Spinal Neoplasms | 1 | 2008 | 760 | 0.050 |
Why?
|
| Prenatal Diagnosis | 1 | 2008 | 1236 | 0.050 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2015 | 3022 | 0.050 |
Why?
|
| Cost-Benefit Analysis | 2 | 2018 | 5391 | 0.050 |
Why?
|
| Boston | 4 | 2015 | 9313 | 0.050 |
Why?
|
| Neuroblastoma | 1 | 2008 | 1226 | 0.050 |
Why?
|
| Drainage | 1 | 2006 | 1142 | 0.050 |
Why?
|
| Adult | 12 | 2020 | 214055 | 0.040 |
Why?
|
| Ubiquitin | 1 | 2005 | 852 | 0.040 |
Why?
|
| Parathyroid Hormone | 1 | 2006 | 1801 | 0.040 |
Why?
|
| Databases, Factual | 2 | 2020 | 7729 | 0.040 |
Why?
|
| Cone-Beam Computed Tomography | 1 | 2023 | 450 | 0.040 |
Why?
|
| Risk Factors | 7 | 2021 | 72290 | 0.040 |
Why?
|
| Liver Neoplasms | 1 | 2015 | 4253 | 0.040 |
Why?
|
| Gene Expression | 3 | 2006 | 7799 | 0.040 |
Why?
|
| Rats | 5 | 2006 | 24260 | 0.040 |
Why?
|
| Thyroid Nodule | 1 | 2005 | 750 | 0.040 |
Why?
|
| Internship and Residency | 1 | 2018 | 5788 | 0.040 |
Why?
|
| Awareness | 1 | 2022 | 640 | 0.040 |
Why?
|
| Angiography | 1 | 2023 | 1639 | 0.040 |
Why?
|
| Glycoproteins | 1 | 2006 | 2263 | 0.040 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2018 | 341 | 0.040 |
Why?
|
| Radiopharmaceuticals | 3 | 2015 | 2645 | 0.040 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2005 | 2015 | 0.040 |
Why?
|
| Kidney | 1 | 2012 | 7186 | 0.030 |
Why?
|
| Bacterial Infections | 1 | 2004 | 1401 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2015 | 20129 | 0.030 |
Why?
|
| Vascular Patency | 1 | 2018 | 886 | 0.030 |
Why?
|
| Cells, Cultured | 3 | 2005 | 19229 | 0.030 |
Why?
|
| Operating Rooms | 1 | 2022 | 817 | 0.030 |
Why?
|
| Cysteine Proteinase Inhibitors | 2 | 2006 | 190 | 0.030 |
Why?
|
| Mentors | 1 | 2020 | 631 | 0.030 |
Why?
|
| Constriction, Pathologic | 1 | 2018 | 1107 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2023 | 19905 | 0.030 |
Why?
|
| Burns | 1 | 2005 | 1815 | 0.030 |
Why?
|
| Perception | 1 | 2020 | 1198 | 0.030 |
Why?
|
| Intraoperative Period | 1 | 2014 | 520 | 0.030 |
Why?
|
| Dipeptides | 2 | 2006 | 409 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 10943 | 0.030 |
Why?
|
| Animals | 7 | 2013 | 168757 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2007 | 12959 | 0.030 |
Why?
|
| Retreatment | 1 | 2013 | 610 | 0.030 |
Why?
|
| Limb Salvage | 1 | 2013 | 433 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2020 | 15076 | 0.020 |
Why?
|
| Primary Graft Dysfunction | 1 | 2011 | 93 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2020 | 2759 | 0.020 |
Why?
|
| Mortality | 1 | 2021 | 2864 | 0.020 |
Why?
|
| Age Distribution | 1 | 2015 | 2902 | 0.020 |
Why?
|
| Fetal Movement | 1 | 2008 | 21 | 0.020 |
Why?
|
| Reoperation | 1 | 2018 | 4201 | 0.020 |
Why?
|
| Enzyme Activation | 2 | 2005 | 3701 | 0.020 |
Why?
|
| Apoptosis | 1 | 2005 | 9727 | 0.020 |
Why?
|
| Survival Rate | 2 | 2014 | 12788 | 0.020 |
Why?
|
| Models, Biological | 1 | 2005 | 9583 | 0.020 |
Why?
|
| Transcription Factors | 2 | 2005 | 12208 | 0.020 |
Why?
|
| Creatinine | 1 | 2013 | 1919 | 0.020 |
Why?
|
| Renal Insufficiency | 1 | 2013 | 804 | 0.020 |
Why?
|
| Self Report | 1 | 2018 | 3558 | 0.020 |
Why?
|
| Rabbits | 1 | 2013 | 4894 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2015 | 3616 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2005 | 12072 | 0.020 |
Why?
|
| Pepstatins | 1 | 2006 | 10 | 0.020 |
Why?
|
| Stents | 1 | 2018 | 3280 | 0.020 |
Why?
|
| Comorbidity | 1 | 2021 | 10388 | 0.020 |
Why?
|
| Spinal Cord Compression | 1 | 2008 | 235 | 0.020 |
Why?
|
| CCAAT-Enhancer-Binding Protein-delta | 1 | 2005 | 27 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2013 | 2170 | 0.020 |
Why?
|
| Myoblasts, Skeletal | 1 | 2006 | 76 | 0.020 |
Why?
|
| Young Adult | 3 | 2020 | 56430 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2018 | 39050 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 3508 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2015 | 4851 | 0.020 |
Why?
|
| Reperfusion Injury | 1 | 2011 | 1026 | 0.020 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2005 | 286 | 0.010 |
Why?
|
| Toes | 1 | 2005 | 206 | 0.010 |
Why?
|
| Prognosis | 2 | 2015 | 29063 | 0.010 |
Why?
|
| Cause of Death | 1 | 2014 | 3584 | 0.010 |
Why?
|
| Recurrence | 1 | 2015 | 8340 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 15540 | 0.010 |
Why?
|
| Hindlimb | 1 | 2005 | 504 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2008 | 1641 | 0.010 |
Why?
|
| Liver | 1 | 2018 | 7474 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2013 | 6538 | 0.010 |
Why?
|
| Caspase 3 | 1 | 2004 | 758 | 0.010 |
Why?
|
| Hydrogen Peroxide | 1 | 2006 | 731 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 57776 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2012 | 2925 | 0.010 |
Why?
|
| Massachusetts | 1 | 2014 | 8663 | 0.010 |
Why?
|
| Delivery, Obstetric | 1 | 2008 | 906 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2023 | 35421 | 0.010 |
Why?
|
| Critical Illness | 1 | 2013 | 2670 | 0.010 |
Why?
|
| Hospital Mortality | 1 | 2014 | 5317 | 0.010 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2008 | 1695 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 12245 | 0.010 |
Why?
|
| Patient Selection | 1 | 2012 | 4215 | 0.010 |
Why?
|
| Gestational Age | 1 | 2008 | 3493 | 0.010 |
Why?
|
| Oligopeptides | 1 | 2004 | 1189 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2011 | 10252 | 0.010 |
Why?
|
| Transfection | 1 | 2006 | 5892 | 0.010 |
Why?
|
| Forkhead Transcription Factors | 1 | 2005 | 1613 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2005 | 2503 | 0.010 |
Why?
|
| Incidence | 1 | 2014 | 20947 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2005 | 4217 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2005 | 2938 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2012 | 7279 | 0.010 |
Why?
|
| Algorithms | 1 | 2015 | 13881 | 0.010 |
Why?
|
| Quality of Life | 1 | 2015 | 12804 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2005 | 8436 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2008 | 11031 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2015 | 40561 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2005 | 4554 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2005 | 4462 | 0.010 |
Why?
|
| Cell Line | 1 | 2006 | 15997 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2005 | 14722 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2005 | 8949 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2008 | 25625 | 0.000 |
Why?
|
| DNA-Binding Proteins | 1 | 2005 | 9648 | 0.000 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2008 | 11524 | 0.000 |
Why?
|
| Adolescent | 1 | 2015 | 85781 | 0.000 |
Why?
|
| Pregnancy | 1 | 2008 | 29144 | 0.000 |
Why?
|
Concepts
(231)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(48)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_